ENDP - Endo International p...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $3.09 | Open | $3.14 |
| Volume | 3.33M | Market Cap | 1.172B |
| Yield | Last Dividend |
| Why Is Endo (ENDP) Down 33% Since Last E... | 03/27/20 |
| Endo (ENDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Stock To Watch: Endo International (ENDP... | 02/12/20 |
| Shares of Endo International plc (ENDP) are down more than 46 percent from their yearly high but have gained a decent 17 percent so far this month.. | |
| Bill Miller's mutual fund crushed the ma... | 01/27/20 |
| Mutual fund manager Bill Miller is famous for beating the stock market for a record 15 years in a row in the 1990s and 2000s, and he's maintained his ... | |
| Endo to Announce Fourth-Quarter and Full... | 01/24/20 |
| /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2019 financial results on February 26, 2020 and m... | |
| Endo Up on Opioid Abuse Settlement Agree... | 01/13/20 |
| Endo (ENDP) settles an ongoing opioid-abuse litigation issue with the state of Oklahoma for $8.75 million. | |
| Why Is Endo (ENDP) Up 12.3% Since Last E... | 12/04/19 |
| Endo (ENDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Endo's (ENDP) BLA for Cellulite Treatmen... | 11/21/19 |
| The FDA accepts Endo's (ENDP) BLA for CCH for the treatment of cellulite in the buttocks. | |
| Endo CEO to step down when successor is ... | 11/06/19 |
| Endo International said this week that Paul Campanelli, president and CEO, will step down when a successor is named. A successor has not yet been appo... | |
| Endo Aesthetics Launches New Campaign El... | 10/28/19 |
| DUBLIN, Oct. 28, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced that Endo Aesthetics launched a "Redefining Scientific Artistry"... | |
| Why Are Endo Shares Trading Lower? | 10/24/19 |
| Endo International plc (NASDAQ: ENDP ) shares were trading lower Thursday after the company announced it will present data on the use of a standing MR... | |
| Cyanocobalamin Injection Market Growth S... | 10/04/19 |
| Oct 04, 2019 (Hitech News Daily via COMTEX) -- Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of this vit... | |
| Endo Files BLA for CCH With the FDA for ... | 09/09/19 |
| Endo International (ENDP) files BLA for collagenase clostridium histolyticum (CCH) for the treatment of cellulite in the buttocks. | |
| Endo International Files BLA for Label E... | 09/09/19 |
| Endo International (ENDP) files BLA for the additional indication of Xiaflex [collagenase clostridium histolyticum (CCH)] for the treatment of celluli... | |
| Endo Gains FDA Nod for Orfadin Generic t... | 09/05/19 |
| Endo (ENDP) receives an FDA approval for the generic equivalent of Swedish Orphan Biovitrum's Orfadin. | |
| Endo Up on Settlement of a Few Cases Rel... | 08/21/19 |
| Endo (ENDP) finally has some good news for investors with the settlement of a few cases in Ohio related to opioid medications. | |
| Are Options Traders Betting on a Big Mov... | 08/21/19 |
| Investors need to pay close attention to Endo (ENDP) stock based on the movements in the options market lately. | |
| Drugmakers Endo, Allergan agree to $15 m... | 08/20/19 |
| Endo International Plc and Allergan Plc have agreed to pay $15 million to avoid going to trial in October in a landmark case by two Ohio counties accu... | |
| Endo's stock soars after settlement agre... | 08/20/19 |
| Shares of Endo International PLC soared 30% in active morning trading Tuesday, after the generic drug maker said it has reached a "settlement in??? | |
| IN BRIEF: Endo competitor seeks stay of ... | 08/13/19 |
| Athenex Inc is seeking to put on hold a ruling that upheld a U.S. Food and Drug Administration policy that bars it from making a compounded blood pres... | |
| Is Endo International (ENDP) A Great Pic... | 08/13/19 |
| Is Endo International Holdings (ENDP) a great pick from the value investor's perspective right now? Read on to know more. | |
| The Daily Biotech Pulse: Novartis Stands... | 08/07/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 6) A... | |
| Endo settles investor case over withdraw... | 08/06/19 |
| Endo International PLC has agreed to pay $82.5 million to resolve a lawsuit accusing the drugmaker of misleading investors by downplaying the risks of... | |
| The Daily Biotech Pulse: Sanofi's Dupixe... | 08/06/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks No biotech stocks hit 52-week highs Monday. Down I... | |
| Endo International (ENDP) Q2 Earnings an... | 08/05/19 |
| Endo (ENDP) delivered earnings and revenue surprises of 10.64% and 0.37%, respectively, for the quarter ended June 2019. Do the numbers hold clues to ... | |
| Judge rejects drug compounding company's... | 08/01/19 |
| A federal judge on Thursday rejected a pharmaceutical company's challenge to a U.S. Food and Drug Administration policy barring the bulk compounding o... | |
| Endo International (ENDP) Expected to Be... | 07/30/19 |
| Endo (ENDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key ex... | |
| Can Endo (ENDP) Keep the Earnings Surpri... | 07/17/19 |
| Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in ... | |
| Morgan Stanley Downgrades Teva, Endo On ... | 07/15/19 |
| Pharmaceutical stocks have been under pressure for the past few trading days, but one Wall Street analyst said the worst is yet to come for a handful ... | |
| Options Traders Expect Huge Moves in End... | 06/21/19 |
| Investors need to pay close attention to Endo (ENDP) stock based on the movements in the options market lately. | |
| The Daily Biotech Pulse: Nuvectra Files ... | 06/12/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 11) ... | |
| Sell rating | 04/02/20 |
| Morgan Stanley maintains Underweight rating and lowers Price Target from $4.00 to $3.00 | |
| Strong Buy rating | 01/03/20 |
| PiperJaffray upgrades from Neutral to Overweight rating and raises Price Target from $5.00 to $7.00 | |
| Date | 2020-02-26 (BMO) | Est. (EPS/Rev.) | $0.57/ 731.43M |
| Actual (EPS/Rev.) | $0.74/ $764.80 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Equity and Teens | Equity and Teens | 63.00 % | Follow |
| smashingdon | Paul | 63.00 % | Follow |
| Symmetry Options | Symmetry Options | 33.00 % | Follow |
| Activ P | Activ P | 8.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
